JG
CBIO

Jefferies Group’s Crescent Biopharma CBIO Stock Holding History

Jefferies Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-313
Closed -$135K – 2717
2019
Q3 		$135K Buy
+313
New +$201K ﹤0.01% 2455
2019
Q2 		– Sell
-596
Closed -$743K – 2658
2019
Q1 		$743K Buy
596
+218
+58% +$250K 0.02% 1419
2018
Q4 		$358K Sell
378
-1,329
-78% -$1.6M 0.01% 1588
2018
Q3 		$2.46M Buy
+1,707
New +$2.58M 0.06% 882
2018
Q1 		– Sell
-539
Closed -$904K – 2427
2017
Q4 		$904K Buy
+539
New +$713K 0.02% 1420

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return